Infection by Pneumocystis jirovecii in patients with severe respiratory infection caused by SARS-CoV-2 is a situation that we must take into account today. Corticotherapy along with other risk factors predisposes to it. It is a diagnostic challenge and, after treatment, the prognosis is favorable. We report the case of a male with severe pneumonia due to SARS-CoV-2 who received corticosteroid treatment, later developing pneumonia due to P. jiroveci.
CITATION STYLE
Vicente, M. A., & Morte, E. (2022). Pneumonia by Pneumocystis jirovecii after COVID-19 in non-HIV patient. Revista Chilena de Infectologia, 39(3), 357–360. https://doi.org/10.4067/s0716-10182022000200357
Mendeley helps you to discover research relevant for your work.